Inventor · disambiguated record
Robert G. Pendleton
Also filed as: PENDLETON ROBERT G
15 granted patents·182 citations·filing 1974–1990
93Inventor score
Top patents by PatentIndex Score
15 records- 0191US4011319APharmaceutical compositions and methods involving benzazepine derivativesSMITHKLINE CORP·Filed 1975·Granted Mar 8, 1977·23 cites·13 claims
- 0290US4128666A4 AND 5-Halo substituted 2-indanamine compoundsSMITHKLINE CORP·Filed 1977·Granted Dec 5, 1978·22 cites·6 claims
- 0381US4673680Aα2 -adrenergic receptor antagonists as modifiers of gastrointestinal motilityPENDLETON ROBERT G·Filed 1985·Granted Jun 16, 1987·40 cites·5 claims
- 0481US4192888APharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferaseSMITHKLINE CORP·Filed 1978·Granted Mar 11, 1980·13 cites·5 claims
- 0577US4218464A4- and 5-Substituted 2,3-dihydro-1H-isoindoles, pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferaseSMITHKLINE CORP·Filed 1979·Granted Aug 19, 1980·8 cites·10 claims
- 0675US4352809AMethod of producing alpha2 antagonismSMITHKLINE CORP·Filed 1981·Granted Oct 5, 1982·9 cites·7 claims
- 0772US3988339APharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferaseSMITHKLINE CORP·Filed 1975·Granted Oct 26, 1976·23 cites·16 claims
- 0871US4228170A7- and/or 8-Sulfur substituted 1,2,3,4-tetrahydroisoquinoline compoundsSMITHKLINE CORP·Filed 1979·Granted Oct 14, 1980·6 cites·13 claims
- 0971US4052506APharmaceutical compositions and method of producing anti-parkinsonism activitySMITHKLINE CORP·Filed 1975·Granted Oct 4, 1977·8 cites·10 claims
- 1064US3939164A7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compoundsSMITHKLINE CORP·Filed 1974·Granted Feb 17, 1976·5 cites·4 claims
- 1162US4849416ATreatment of conditions requiring enhanced oxygen availability to mammalian tissuesRORER PHARMACEUTICAL CORP·Filed 1988·Granted Jul 18, 1989·12 cites·21 claims
- 1243US4208430APharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferaseSMITHKLINE CORP·Filed 1979·Granted Jun 17, 1980·4 cites·9 claims
- 1336US4062961APharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferaseSMITHKLINE CORP·Filed 1976·Granted Dec 13, 1977·1 cites·8 claims
- 1435US4948582ATreatment of conditions requiring enhanced oxygen availability to mammalian tissuesRORER PHARMACEUTICAL CORP·Filed 1989·Granted Aug 14, 1990·5 cites·24 claims
- 1532US5015663ATreatment of conditions requiring enhanced oxygen availability of mammalian tissuesRHONE POULENC RORER PHARMA·Filed 1990·Granted May 14, 1991·3 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →